Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function

Background—Left ventricular dysfunction is an indication for aortic valve replacement (AVR) in patients with severe aortic regurgitation (AR). However, the postoperative outcome of patients with severe AR and a markedly low ejection fraction (EF) is not known. Methods and Results—The study group consisted of a total of 450 patients who had AVR for isolated AR between 1980 and 1995. Patients with markedly reduced left ventricular function (EF <35%, LoEF, n=43) were compared with those with moderate reduction in left ventricular function (EF 35% to 50%, MedEF, n=134) and those with normal left ventricular function (EF ≥50%, Nl EF, n=273). The operative mortality rate was higher with LoEF (14%) than with MedEF and Nl EF (6.7% and 3.7%, respectively, P =0.02). At 10 years, 41%±9% of LoEF patients had survived compared with 56%±5% and 70%±3% of MedEF and Nl EF patients, respectively (P <0.0001). Congestive heart failure occurred at 10 years in 25%±9% with LoEF compared with 17%±4% and 9%±2% with MedEF and NL EF, respectively (P <0.003). Postoperative EF improved by 4.9%±13.8% in the LoEF group and by 4%±11.9% in the MedEF group compared with −2.3%±10.9% in the Nl EF group (P <0.002 and P <0.0001, respectively). Conclusions—Patients with severe AR and markedly low EF incur excess operative mortality rates, postoperative mortality rates, and congestive heart failure after AVR. However, postoperative EF improves markedly, and most patients enjoy a long postoperative survival without recurrence of heart failure after AVR; thus they should not be denied the benefits of AVR.

[1]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[2]  G. Fonarow How old is too old for heart transplantation? , 2000, Current opinion in cardiology.

[3]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[4]  M. Enriquez-Sarano,et al.  Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. , 1999, Circulation.

[5]  R. Gibbons,et al.  ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.

[6]  P. Kligfield,et al.  Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. , 1998, Circulation.

[7]  R. Gibbons,et al.  ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.

[8]  M. Enriquez-Sarano,et al.  Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction. , 1996, Journal of the American College of Cardiology.

[9]  M. Enriquez-Sarano,et al.  Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. , 1995, Circulation.

[10]  S. Rahimtoola,et al.  Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. , 1994, The New England journal of medicine.

[11]  W. Aronow,et al.  Prognosis of patients with heart failure and unoperated severe aortic valvular regurgitation and relation to ejection fraction. , 1994, The American journal of cardiology.

[12]  M. Enriquez-Sarano,et al.  Echocardiographic Prediction of Survival After Surgical Correction of Organic Mitral Regurgitation , 1994, Circulation.

[13]  H. Nawaz,et al.  Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation. , 1991, Circulation.

[14]  R. Bonow,et al.  Serial Long‐term Assessment of the Natural History of Asymptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Systolic Function , 1991, Circulation.

[15]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[16]  R. Bonow,et al.  Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. , 1988, Circulation.

[17]  N C Nanda,et al.  Evaluation of aortic insufficiency by Doppler color flow mapping. , 1987, Journal of the American College of Cardiology.

[18]  R. Bonow,et al.  Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. , 1985, Circulation.

[19]  J. Spann,et al.  Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. , 1984, Journal of the American College of Cardiology.

[20]  P. Serruys,et al.  Echocardiography in Chronic Aortic Insufficiency: Is Valve Replacement Too Late When Left Ventricular End-systolic Dimension Reaches 55 mm? , 1983, Circulation.

[21]  S. Rich,et al.  Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography. , 1982, American heart journal.

[22]  N. Reichek,et al.  Noninvasive Determination of Left Ventricular End‐systolic Stress: Validation of the Method and Initial Application , 1982, Circulation.

[23]  M. Quiñones,et al.  Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume. , 1978, Chest.

[24]  D J Hagler,et al.  Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. , 1978, Mayo Clinic proceedings.

[25]  C. Lillehei,et al.  LEFT RETROGRADE CARDIOANGIOGRAPHY IN ACQUIRED CARDIAC DISEASE: TECHNIC, INDICATIONS AND INTERPRETATIONS IN 700 CASES. , 1964, The American journal of cardiology.